Asensus Surgical Inc
F:2TX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Asensus Surgical Inc
F:2TX
|
US |
|
Tainwala Chemicals and Plastics (India) Ltd
NSE:TAINWALCHM
|
IN |
|
Bright Health Group Inc
NYSE:NEUE
|
US |
|
J
|
JF Technology Bhd
KLSE:JFTECH
|
MY |
|
L
|
Linmon Media Ltd
HKEX:9857
|
CN |
|
Kanoria Chemicals and Industries Ltd
NSE:KANORICHEM
|
IN |
|
F
|
Fujian Jinsen Forestry Co Ltd
SZSE:002679
|
CN |
|
Voyager Digital Ltd
TSX:VOYG
|
US |
|
A
|
Ashnoor Textile Mills Ltd
BSE:507872
|
IN |
|
KIOCL Ltd
NSE:KIOCL
|
IN |
|
C
|
Compania Electrica del Litoral SA
SGO:LITORAL
|
CL |
|
NX Filtration NV
AEX:NXFIL
|
NL |
|
Alpha MOS SA
PAR:ALNEO
|
FR |
|
Liberty Media Corp
NASDAQ:FWONA
|
US |
|
InVision AG
XETRA:IVX
|
DE |
Asensus Surgical Inc
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 183 full-time employees. The firm is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The firm is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 183 full-time employees. The firm is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The firm is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
